Department of Biological Sciences, Faculty of Science, Thompson Rivers University, Kamloops, BC, Canada.
Department of Microbiology and Biotechnology, Vilnius University, Lithuania.
Biochem Pharmacol. 2017 Jun 15;134:18-34. doi: 10.1016/j.bcp.2016.11.018. Epub 2016 Nov 17.
This review highlights cave habitats, cave microbiomes and their potential for drug discovery. Such studies face many challenges, including access to remote and pristine caves, and sample collection and transport. Inappropriate physical and chemical growth conditions in the laboratory for the isolation and cultivation of cave microorganisms pose many complications including length of cultivation; some cave microorganisms can take weeks and even months to grow. Additionally, DNA extraction from cave environmental samples may be difficult due to the high concentration of various minerals that are natural DNA blocking agents. Once cave microorganisms are grown in the lab, other problems often arise, such as maintenance of pure culture, consistency of antimicrobial activity and fermentation conditions for antimicrobial production. In this review, we suggest that, although based on what has been done in the field, there is potential in using cave microorganisms to produce antimicrobial agents, one needs to be highly committed and prepared.
这篇综述重点介绍了洞穴栖息地、洞穴微生物组及其在药物发现方面的潜力。这些研究面临着许多挑战,包括进入偏远且原始的洞穴,以及样本采集和运输。在实验室中为分离和培养洞穴微生物创造不合适的物理和化学生长条件会带来许多并发症,包括培养时间;一些洞穴微生物可能需要数周甚至数月才能生长。此外,由于天然 DNA 阻断剂的各种矿物质浓度较高,从洞穴环境样本中提取 DNA 可能很困难。一旦洞穴微生物在实验室中生长,通常会出现其他问题,例如纯培养物的维持、抗菌活性的一致性以及抗菌生产的发酵条件。在这篇综述中,我们认为,尽管基于已经在该领域中所做的工作,利用洞穴微生物来生产抗菌剂具有潜力,但需要高度投入和准备。